Similar Posts
Possible study of anthrax vaccine’s effectiveness in children stirs debate/WaPo
The people on the NBSB could only come up with a recommendation to test anthrax vaccine on children if they were ignorant about the vaccine and/or the law’s requirements for testing children under 45 CFR 46.407. I will have much more to say about this unfolding story over the next few days. Here is Rob…
More pictures +/- the complete exosporium
Here (or here, if you are having trouble viewing the first set of images) is a side by side comparison of the Sandia pictures (from Anonymous) with pictures of 2 different batches of anthrax spores from another paper. One picture shows anthrax spores WITH an intact exosporium, the other WITHOUT an intact exosporium. Clearly the…
Novartis: We have done no testing for the carcinogenicity of MF59
At the 12/2008 FDA-NIH meeting on how to study novel adjuvants, Novartis scientist (Novartis owns the MF59 adjuvant) Dr. Novicki made the following statement: “Carcinogenicity–we have done no testing for the carcinogenicity of MF59 adjuvant or any of our preventive vaccines. We haven’t done it and we don’t plan to.” (See page 391.) And if…
Don’t Worry Americans, We’re Just Going Through You to Get to Him / Editorial Cartoon
http://www.gocomics.com/stevebenson/2013/09/08#.UqKtwmRDsrd Steve Benson by Steve Benson September 08, 2013 Previous feature Next feature Current
Pfizer CEO: “Two doses of the vaccine offers very limited protection, if any. 3 doses with a booster offer reasonable protection against hospitalization and deaths. Less protection against infection.” 39 secs
Jordan Schactel has presented Pfizer CEO Albert Bourla’s statement to media yesterday, which is otherwise behind a paywall. The statement is critically important for the Supreme Court mandate cases, because both the OSHA case and healthcare worker case require only the first two vaccinations (“fully vaccinated”). Veterinarian Bourla admits these 2 doses provide “very limited…
Anthrax Suspicions (Washington Post Editorial)
Anthrax Suspicions: Why an independent look at the FBI probe is essential Friday, September 19, 2008; Page A18 THERE’S NO better proof of the need for an independent review of the FBI’s anthrax investigation than the words of Sen. Patrick J. Leahy (D-Vt.). Mr. Leahy was one of the intended recipients of anthrax-filled letters sent…